Literature DB >> 2993926

Antihypertensive mechanism of action of ketanserin and some ketanserin analogues in the spontaneously hypertensive rat.

A Pettersson, K Gradin, T Hedner, B Persson.   

Abstract

Ketanserin is a new antihypertensive agent with affinity to serotonin (5-HT)2 receptors and at higher concentrations also to alpha 1-adrenoceptors. The present study was designed to evaluate the relative functional importance of the antagonism of alpha 1-adrenoceptors and 5-HT2-receptors in the antihypertensive mechanism of action of ketanserin and analogues after acute administration. In the spontaneously hypertensive rat, ketanserin and the two ketanserin analogues, R56413 and R55667 (which have relatively weaker alpha-adrenolytic properties) were studied with regard to their ability to reduce the blood pressure after acute administration in the conscious rat and their ability to shift the dose response curves for 5-HT and phenylephrine in the pithed rat. The agents tested reduced the blood pressure only in a dose range where they blocked alpha 1-adrenoceptors and there was a striking correlation between the degree of hypotension and the degree of inhibition of the phenylephrine induced pressor responses. 5-HT2-receptor blockade alone did not influence basal blood pressure. However, following pretreatment with R55667 in a low dose the blood pressure reduction to prazosin was enhanced. It is concluded that following acute administration in the rat the major portion of the antihypertensive response to ketanserin is due to an alpha 1-adrenoceptor blockade but that the 5-HT2-receptor blockade contributes.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2993926     DOI: 10.1007/bf00496374

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  19 in total

1.  A pithed rat preparation suitable for assaying pressor substances.

Authors:  R E SHIPLEY; J H TILDEN
Journal:  Proc Soc Exp Biol Med       Date:  1947-04

2.  A method of stimulating the complete sympathetic outflow from the spinal cord to blood vessels in the pithed rat.

Authors:  J S Gillespie; T C Muir
Journal:  Br J Pharmacol Chemother       Date:  1967-05

3.  Ketanserin--a novel antihypertensive drug?

Authors:  P P Humphrey; W Feniuk; A D Watts
Journal:  J Pharm Pharmacol       Date:  1982-08       Impact factor: 3.765

4.  Mechanism of the hypotensive effect of ketanserin.

Authors:  J R Fozard
Journal:  J Cardiovasc Pharmacol       Date:  1982 Sep-Oct       Impact factor: 3.105

5.  Receptor binding profile of R 41 468, a novel antagonist at 5-HT2 receptors.

Authors:  J E Leysen; F Awouters; L Kennis; P M Laduron; J Vandenberk; P A Janssen
Journal:  Life Sci       Date:  1981-03-02       Impact factor: 5.037

6.  Experience with ketanserin, a serotonin (S2) antagonist, in longterm treatment of essential hypertension.

Authors:  T Hedner; B Persson; G Berglund
Journal:  Clin Exp Hypertens A       Date:  1984

7.  Vascular effects of ketanserin (R 41 468), a novel antagonist of 5-HT2 serotonergic receptors.

Authors:  J M Van Nueten; P A Janssen; J Van Beek; R Xhonneux; T J Verbeuren; P M Vanhoutte
Journal:  J Pharmacol Exp Ther       Date:  1981-07       Impact factor: 4.030

8.  An examination of factors influencing adrenergic transmission in the pithed rat, with special reference to noradrenaline uptake mechanisms and post-junctional alpha-adrenoceptors.

Authors:  J R Docherty; J C McGrath
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-08       Impact factor: 3.000

9.  Centrally mediated antihypertensive and bradycardic effects of methysergide in spontaneously hypertensive rats.

Authors:  M J Antonaccio; D Coté
Journal:  Eur J Pharmacol       Date:  1976-04       Impact factor: 4.432

10.  Antihypertensive effects of chronic 5-hydroxytryptamine (5-HT2) receptor blockade with ketanserin in the spontaneously hypertensive rat.

Authors:  A Pettersson; B Persson; M Henning; T Hedner
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-08       Impact factor: 3.000

View more
  8 in total

1.  Analysis of the mechanism underlying the vasodilator action of carvedilol in pithed spontaneously hypertensive rats.

Authors:  H Hashimoto; M Tanaka; A Kanda; A Akashi
Journal:  Drugs       Date:  1988       Impact factor: 9.546

2.  Haemodynamic changes associated with long term antihypertensive therapy with ketanserin.

Authors:  H Noda; M Isaka; Y Ito; T Fujita
Journal:  Drugs       Date:  1988       Impact factor: 9.546

3.  Antihypertensive effects of chronic 5-hydroxytryptamine (5-HT2) receptor blockade with irindalone in the spontaneously hypertensive rat.

Authors:  K Gradin; T Hedner; B Persson
Journal:  J Neural Transm Gen Sect       Date:  1991

4.  Pharmacokinetics of ketanserin in patients with essential hypertension.

Authors:  B Persson; A Pettersson; T Hedner
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

5.  Cardiovascular effects of intrathecal administration of substance P in the rat: interactions with serotonergic mechanisms.

Authors:  K Gradin; B Persson
Journal:  J Neural Transm Gen Sect       Date:  1992

6.  Serotonin-induced platelet aggregation predicts the antihypertensive response to serotonin receptor antagonists.

Authors:  G Gleerup; B Persson; T Hedner; K Winther
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

7.  In vivo and in vitro activity of selective 5-hydroxytryptamine2 receptor antagonists.

Authors:  S Conolan; M J Quinn; D A Taylor
Journal:  Br J Pharmacol       Date:  1986-09       Impact factor: 8.739

8.  Interference of ketanserin with baroreflex control of the circulation in the conscious spontaneously hypertensive rat.

Authors:  J Smits; F van Dorsten; H Struyker Boudier
Journal:  Drugs       Date:  1988       Impact factor: 9.546

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.